NCT00659659 - A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

March 31, 2011

Conditions

Asthma

Interventions

DRUG

MEDI-563

1.0 mg/kg IV: MEDI-563

DRUG

MEDI-563

100 mg, 200 mg SC

OTHER

Placebo Comp.

Placebo SC

OTHER

Placebo

Placebo as a single IV infusion (Certain number of subjects)

Trial Locations (11)

Research Site, Pittsburgh

Research Site, Madison

Research Site, Houston

Research Site, Denver

Research Site, Galveston

Research Site, Houston

Research Site, Vancouver

Research Site, Calgary

Research Site, Hamilton

Research Site, Montreal

Research Site, Québec